Tufts Medical Center
276
23
37
169
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.8%
52 terminated/withdrawn out of 276 trials
76.5%
-10.1% vs industry average
13%
36 trials in Phase 3/4
50%
85 of 169 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (276)
Bempedoic Acid Therapy for Polycystic Kidney Disease
Role: collaborator
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
Role: lead
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
Role: lead
Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care
Role: collaborator
Enhancing BodyWorks: A Canine Health Literacy Module
Role: collaborator
Oncoplastic Surgery Outcomes Database
Role: lead
Feasibility of Remote Tai Chi
Role: collaborator
Community Walks: Clinical Trial
Role: lead
Music Use in Parturients Admitted to Labor & Delivery
Role: lead
Statins In Intracerbral Hemorrhage
Role: collaborator
Glycemic Observation and Metabolic Outcomes in Mothers and Offspring
Role: collaborator
Pulmonary Embolism and Right-to-Left Shunts
Role: lead
HCMR Re-Imaging Study
Role: collaborator
Improving Medical Decision Making for Older Patients With End Stage Renal Disease
Role: lead
Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia
Role: lead
I Kua na'u Advance Care Planning for Native Hawaiian Elders
Role: lead
Vitamin D and Type 2 Diabetes - Treat-To-Target
Role: lead
Improving PRO for Patients With Cancer Using ECAs and Data Visualization
Role: lead
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants
Role: collaborator
Lung Ultrasound-Guided Respiratory Management in Infants
Role: lead